Phase II Study of Neoadjuvant ArOMatase Inhibitor Therapy for ER+ Breast Cancer (NAOMI)
Clinical trial NCT04568616 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT04568616
- Sponsor
- Dartmouth-Hitchcock Medical Center
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2021-08-13
- Primary completion
- 2028-04-02
- Enrollment
- 178
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.